8-K
filed February 23, 2023, 6:59 PM ET
ticker KWR
CIK 0000081362
earnings
confidence high
sentiment negative
materiality 0.75
Quaker Houghton Q4 net loss $76M on $93M goodwill impairment; non-GAAP EPS $1.39
QUAKER CHEMICAL CORP
2022-FY EPS reported
-$0.89
revenue$1,943,585,000
- Q4 net sales $484.8M (+8% YoY) driven by 24% price/mix; volumes down 10%.
- Full year 2022 net sales record $1.94B; net loss $15.9M vs net income $121.4M in 2021.
- Non-GAAP Q4 EPS $1.39 vs $1.29 YoY; adjusted EBITDA $67.9M (+12% YoY).
- EMEA segment goodwill impairment of $93M due to inflation, rising rates, Ukraine war.
- Operating cash flow $68.1M in Q4; net debt to adjusted EBITDA 3.0x at year-end.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
QUAKER CHEMICAL CORP reported twelve months ended December 31, 2022 results: revenue $1.9 billion, net income (15,931), EPS (0.89).
- Period
- twelve months ended December 31, 2022
- Revenue
- $1.9 billion
- Net income
- (15,931)
- EPS
- (0.89)
- Result
- reported results
Exact text from the filing
FOURTH QUARTER AND FULL YEAR 2022 RESULTS • Q4’22 net sales of $484.8 million increased 8% compared to Q4’21 driven by higher selling prices • Record full year 2022 net sales of $1.9 billion primarily driven by value-based pricing initiatives • Q4’22 net loss of $76.0 million and net loss per diluted share of $4.24 which includes a $93.0 million impairment charge •
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
QUAKER CHEMICAL CORP reported three months ended December 31, 2022 results: revenue $484.8 million, net income $76.0 million, EPS $4.24.
- Period
- three months ended December 31, 2022
- Revenue
- $484.8 million
- Net income
- $76.0 million
- EPS
- $4.24
- Result
- reported results
Exact text from the filing
Q4’22 net sales of $484.8 million increased 8% compared to Q4’21 driven by higher selling prices • Record full year 2022 net sales of $1.9 billion primarily driven by value-based pricing initiatives • Q4’22 net loss of $76.0 million and net loss per diluted share of $4.24 which includes a $93.0 million impairment charge
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.